| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/10/1990 | EP0350118A2 Spiro-azabicyclic muscarinic agonists |
| 01/10/1990 | EP0350051A1 Thaz derivatives for enhancemet of cerebral function |
| 01/10/1990 | EP0349956A1 Azacyclic compounds and their preparation und use |
| 01/10/1990 | EP0349609A1 Aminoacid esters, process for their manufacture and their use |
| 01/10/1990 | EP0349589A1 Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease |
| 01/10/1990 | EP0349545A1 New cardiodilatin fragment, process for preparing same and use thereof. |
| 01/10/1990 | CN1038646A Basic-substituted 5-halo-thienoisothiazol-3(2h)-one 1,1-dioxides,a process for preparation thereof, and pharmaceutical preparations containing these compounds |
| 01/10/1990 | CN1038644A Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
| 01/10/1990 | CN1038585A Clear away heart-fire liquid and process for preparing same |
| 01/09/1990 | US4892883 Pharmaceutical compositions containing bilobalide for the treatment of neuropathies Ai |
| 01/09/1990 | US4892878 Neuroleptic agents |
| 01/09/1990 | US4892872 Benzoxazine compounds and pharmaceutical use thereof |
| 01/09/1990 | US4892870 Analgesics, antiinflammatory agents, antipyretics, immunomodulating agents |
| 01/09/1990 | US4892739 Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties |
| 01/09/1990 | CA1264321A1 7-¬(substituted)amino|-8-¬substituted(carbonyl)- methyl-amino|-1-oxaspiro¬4.5|decanes as analgesic agents |
| 01/03/1990 | EP0349424A1 20,21-Dinoreburnamenine derivatives substituted in position 15 by an amino group and their salts, process for their preparation and the intermediates so obtained, their use as medicines and pharmaceutical compositions containing them |
| 01/03/1990 | EP0348891A2 Lactamimides as calcium antagonists |
| 01/03/1990 | EP0348872A1 Fused dihydroxyquinoxalines and their use as glutamate antagonists |
| 01/03/1990 | EP0348683A1 Pharmaceutical compositions containing ibuprofen in combination with a piperidinoalkanol antihistamine |
| 01/03/1990 | EP0348392A1 8-alkylaminoimidazo[1,2-a]pyrazines and derivatives, their preparation and their application in therapy |
| 01/02/1990 | US4891386 Lidocaine derivative and therapeutic compositions which contain it as principal active ingredient |
| 01/02/1990 | US4891383 Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin and a method for their preparation |
| 01/02/1990 | US4891381 Derivatives of 5-pentylamino-5-oxopentanoil and 4-pentlamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin |
| 01/02/1990 | US4891378 Cerebral insufficiency |
| 01/02/1990 | US4891376 Migraine |
| 01/02/1990 | CA1264160A1 Amides, their preparation, and pharmaceuticals containing same |
| 12/28/1989 | WO1989012677A1 Superoxide dismutase analogs having novel binding properties |
| 12/28/1989 | WO1989012445A1 Method and compositions for treatment of parkinsonism syndrome in mammals |
| 12/27/1989 | EP0348360A2 Pharmacological use of uridine in the treatment of nervous disorders |
| 12/27/1989 | EP0348353A2 The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases |
| 12/27/1989 | EP0348257A2 (Hetero)aryl-diazole derivatives, process for their preparation and their therapeutical use |
| 12/27/1989 | EP0347831A2 Pyridine derivatives and intermediates thereof |
| 12/27/1989 | EP0347802A2 Neurokinin A antagonists |
| 12/27/1989 | EP0347766A2 4,5,7,8-Tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and their use as medicaments |
| 12/27/1989 | EP0347672A1 Benzazepine derivatives |
| 12/27/1989 | EP0347436A1 Bradykinin antagonist peptides |
| 12/27/1989 | CN1038306A Recombinant retroviruses |
| 12/27/1989 | CN1038283A Amino acid ester pharmaceuticals containg same and use thereof |
| 12/27/1989 | CN1038280A Prepn. of formylamide derivatives |
| 12/26/1989 | US4889854 Tricyclic pyridone derivatives |
| 12/26/1989 | US4889853 Hydroquinonlyphenyl butyric acid amide derivative |
| 12/26/1989 | US4889852 Anxiolytically active piperazine derivatives |
| 12/20/1989 | EP0347094A1 Imidazoquinoxaline compounds and their preparation and use |
| 12/20/1989 | EP0347066A1 New enantiomers and their isolation |
| 12/20/1989 | EP0347056A1 Essential fatty acid compositions |
| 12/20/1989 | EP0346927A2 Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridine-carboxylic acids and derivatives thereof |
| 12/20/1989 | EP0346791A1 1,2-diarylethylamines for treatment of neurotoxic injury |
| 12/20/1989 | EP0346683A1 Pyrrole derivatives, their preparation and their use |
| 12/20/1989 | EP0346445A1 Dextrorphan potentiator for anticonvulsant composition and method |
| 12/20/1989 | EP0346431A1 Onset-hastened/enhanced analgesia using s(+) ketoprofen |
| 12/20/1989 | EP0346419A1 Amino-4 trifluoromethyl-1 tetraline derivatives, their preparation and therapeutic application. |
| 12/20/1989 | CN1038100A Process for preparation of alpha-adrenergic receptor antagonists |
| 12/20/1989 | CN1038021A Pharmaceutical compositions for piperidino alkanol-ibuprofen combination |
| 12/19/1989 | US4888433 Process for the preparation of optically active alpha-arylalkanoic acids and novel intermediates thereof |
| 12/19/1989 | US4888427 Dihydropyridine-pyridinium salt redox system |
| 12/19/1989 | US4888359 Analgesic and antiinflammatory pharmaceutical composition containing a naphthyl-acetic acid derivative |
| 12/19/1989 | US4888355 Indanes and their use as antiarrhythmic agents |
| 12/19/1989 | US4888351 Treatment of cerebral edema |
| 12/19/1989 | US4888347 Use of specific N-methyl-D-aspartate receptor antagonists in the prevention and treatment of neurodegeneration |
| 12/19/1989 | US4888178 Sustained release |
| 12/19/1989 | CA1263957A1 Quinolylglycinamide derivatives, process for their preparation and their therapeutical use as psychotropic drug |
| 12/19/1989 | CA1263954A1 Ganglioside derivatives |
| 12/14/1989 | WO1989012067A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
| 12/14/1989 | WO1989012054A1 alpha-ADRENERGIC RECEPTOR ANTAGONISTS |
| 12/14/1989 | WO1989012053A1 alpha-ADRENERGIC RECEPTOR ANTAGONISTS |
| 12/14/1989 | WO1989012050A1 alpha-ADRENERGIC RECEPTOR ANTAGONISTS |
| 12/14/1989 | WO1989012048A1 Cis-2,6-diazabicyclo[3.3.0]octane derivatives and their medicinal use |
| 12/14/1989 | WO1989011855A1 Stable pharmaceutical composition |
| 12/14/1989 | WO1989011854A1 Pharmacological treatment of ocular development |
| 12/13/1989 | EP0346238A1 Analgesic phenothiazine derivatives |
| 12/13/1989 | EP0346208A1 4-Amino quinolines and naphthyridines, process for their preparation and their use as medicaments |
| 12/13/1989 | EP0346207A1 4-Amino-3-carboxynaphthyridine derivatives, their preparation and pharmaceutical compositions |
| 12/13/1989 | EP0346115A1 Morpholine derivatives |
| 12/13/1989 | EP0345956A1 Tricyclic ketones |
| 12/13/1989 | EP0345948A2 Use of 5-HT1A agonists for the manufacture of a medicament protecting against ischaemic damage |
| 12/13/1989 | EP0345883A2 Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine |
| 12/13/1989 | EP0345808A1 1-Indolylalkyl-4-(substituted-pyridinyl)piperazines |
| 12/13/1989 | EP0345629A2 Condensed diazepinones, process for their preparation and medicaments containing them |
| 12/13/1989 | EP0345592A1 Novel 2-substituted coumaran derivatives |
| 12/13/1989 | EP0345304A1 Pharmaceutical compositions |
| 12/13/1989 | CN1037834A Composition based on hydrate lamellar lipides or liposomes, containing extract of scutellaria, or at least component thereof, and cosmeties or pharmaceutical, especially having anti-allergic,......... |
| 12/12/1989 | US4886817 Imidazolidinones as brain activators |
| 12/12/1989 | US4886808 Indazolyl carboxylic acid amides useful for treating migraine clusters headache, trigeminal neuralgia or emesis |
| 12/12/1989 | US4886805 Novel aminoalkylthio derivatives of triazolopyridine or triazoloquinoline, the processes for their preparation, and drugs, useful especially as analgesics, in which they are present |
| 12/12/1989 | US4886802 17-aza-20,21, dinoreburnamenines |
| 12/12/1989 | US4886800 Substituted cinnoline derivatives as CNS depressants |
| 12/12/1989 | US4886797 Central nervous system disorders |
| 12/12/1989 | US4886791 Therapy of liver disorders |
| 12/12/1989 | US4886750 Process for the preparation of a pharmaceutically active compound in a stereospecific form of the formula |
| 12/06/1989 | EP0345248A2 Use of the enzyme-cofactor NADPH in the preparation of a pharmaceutical, pharmaceutical and preparation thereof |
| 12/06/1989 | EP0345247A2 Use of monosubstitute selenium compounds in the preparation of a pharmaceutical, pharmaceutical and preparation thereof |
| 12/06/1989 | EP0345068A2 Agonist of gamma-aminobutyric acid |
| 12/06/1989 | EP0345056A2 Improvements in and relating to serotonin antagonists |
| 12/06/1989 | EP0344995A2 Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ace inhibitor |
| 12/06/1989 | EP0344981A2 Alpha-adrenergic receptor antagonists |
| 12/06/1989 | EP0344980A2 Alpha-adrenergic receptor antagonists |
| 12/06/1989 | EP0344979A2 Alfa-adrenergic receptor antagonists |
| 12/06/1989 | EP0344943A1 Imidazoquinoxaline compounds and their preparation and use |
| 12/06/1989 | EP0344840A2 Transdermal delivery systems |
| 12/06/1989 | EP0344675A2 Method for the production of selegiline hydrochloride |